Schneider LS - Search Results

1

Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial.

Sultzer DL, Davis SM, Tariot PN, Dagerman KS, Lebowitz BD, Lyketsos CG, Rosenheck RA, Hsiao JK, Lieberman JA, Schneider LS; CATIE-AD Study Group. Sultzer DL, et al. Among authors: schneider ls. Am J Psychiatry. 2008 Jul;165(7):844-54. doi: 10.1176/appi.ajp.2008.07111779. Epub 2008 Jun 2. Am J Psychiatry. 2008. PMID: 18519523 Free PMC article. Clinical Trial.

2

Provisional diagnostic criteria for depression of Alzheimer disease.

Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC, Bruce ML, Caine ED, Cummings JL, Devanand DP, Krishnan KR, Lyketsos CG, Lyness JM, Rabins PV, Reynolds CF 3rd, Rovner BW, Steffens DC, Tariot PN, Lebowitz BD. Olin JT, et al. Among authors: schneider ls. Am J Geriatr Psychiatry. 2002 Mar-Apr;10(2):125-8. Am J Geriatr Psychiatry. 2002. PMID: 11925273

3

Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background.

Olin JT, Katz IR, Meyers BS, Schneider LS, Lebowitz BD. Olin JT, et al. Among authors: schneider ls. Am J Geriatr Psychiatry. 2002 Mar-Apr;10(2):129-41. Am J Geriatr Psychiatry. 2002. PMID: 11925274 Review.

4

Increasing ethnic minority participation in Alzheimer disease research.

Olin JT, Dagerman KS, Fox LS, Bowers B, Schneider LS. Olin JT, et al. Among authors: schneider ls. Alzheimer Dis Assoc Disord. 2002;16 Suppl 2:S82-5. doi: 10.1097/00002093-200200002-00009. Alzheimer Dis Assoc Disord. 2002. PMID: 12351920 Review.

5

An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.

Schneider LS, Nelson JC, Clary CM, Newhouse P, Krishnan KR, Shiovitz T, Weihs K; Sertraline Elderly Depression Study Group. Schneider LS, et al. Am J Psychiatry. 2003 Jul;160(7):1277-85. doi: 10.1176/appi.ajp.160.7.1277. Am J Psychiatry. 2003. PMID: 12832242 Clinical Trial.

6

Psychosis of Alzheimer disease: validity of the construct and response to risperidone.

Schneider LS, Katz IR, Park S, Napolitano J, Martinez RA, Azen SP. Schneider LS, et al. Am J Geriatr Psychiatry. 2003 Jul-Aug;11(4):414-25. Am J Geriatr Psychiatry. 2003. PMID: 12837670 Clinical Trial.

7

Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's disease trial.

Schneider LS, Ismail MS, Dagerman K, Davis S, Olin J, McManus D, Pfeiffer E, Ryan JM, Sultzer DL, Tariot PN. Schneider LS, et al. Schizophr Bull. 2003;29(1):57-72. doi: 10.1093/oxfordjournals.schbul.a006991. Schizophr Bull. 2003. PMID: 12908661

8

Efficacy of controlled-release paroxetine in the treatment of late-life depression.

Rapaport MH, Schneider LS, Dunner DL, Davies JT, Pitts CD. Rapaport MH, et al. Among authors: schneider ls. J Clin Psychiatry. 2003 Sep;64(9):1065-74. doi: 10.4088/jcp.v64n0912. J Clin Psychiatry. 2003. PMID: 14628982 Clinical Trial.

9

Psychosis of Alzheimer's disease: clinical characteristics and history.

Schneider LS, Dagerman KS. Schneider LS, et al. J Psychiatr Res. 2004 Jan;38(1):105-11. doi: 10.1016/s0022-3956(03)00092-x. J Psychiatr Res. 2004. PMID: 14690773 Review.

10

Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'.

Rosenberg PB, Onyike CU, Katz IR, Porsteinsson AP, Mintzer JE, Schneider LS, Rabins PV, Meinert CL, Martin BK, Lyketsos CG; Depression of Alzheimer's Disease Study. Rosenberg PB, et al. Among authors: schneider ls. Int J Geriatr Psychiatry. 2005 Feb;20(2):119-27. doi: 10.1002/gps.1261. Int J Geriatr Psychiatry. 2005. PMID: 15660424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

619 results

Search Page